11 – 20 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-na
- Contribution to journal › Article
-
Mark
Differential Effects of Efavirenz, Lopinavir/r, and Atazanavir/r on the Initial Viral Decay Rate in Treatment Naive HIV-1-Infected Patients
(
- Contribution to journal › Article
-
Mark
Increased risk of abdominal wall hernia associated with combination anti-retroviral therapy in HIV-infected patients-results from a Swedish cohort-study
(
- Contribution to journal › Article
- 2009
-
Mark
CONTINUED HEAVY TRANSMISSION OF HCV IN A NEEDLE EXCHANGE PROGRAM THAT IS ASSOCIATED WITH MINIMAL TRANMISSION OF HIV. A NINE YEAR LONGITUDINAL COHORT STUDY
2009) 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver In Journal of Hepatology 50(Suppl 1). p.161-161(
- Contribution to journal › Published meeting abstract
-
Mark
Treatment of HIV infection: Swedish recommendations 2009
(
- Contribution to journal › Scientific review
- 2008
-
Mark
CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4 beta-hydroxycholesterol levels
(
- Contribution to journal › Article
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2007
(
- Contribution to journal › Scientific review
-
Mark
Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patients.
(
- Contribution to journal › Article
- 2007
-
Mark
Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART.
(
- Contribution to journal › Article
- 2004
-
Mark
GB virus C viraemia and HIV progression: cause or effect?
(
- Contribution to journal › Letter